The ProPublica article on U. S. dialysis industry posted recently has been touted as duping and misinterprets data, outlined officials of Denver-based DaVita Inc., the nation's largest dialysis provider.
Recent figures suggest that the mortality rate of U. S. kidney patients is higher compared to other industrialized countries. The mortality rate has registered a steady slip, and patients generally receive high-quality care, claimed Dr. Allen Nissenson, chief medical officer of DaVita.
Figures compiled by the U. S. Renal Data System, the mortality rate of U. S. dialysis patients has marked a slip by over 8.5 % since 2002, from 231.3 per 1,000 patients that year touching 211.7 in 2007, posted DaVita officials.
The payment policies framed by the government for dialysis is claimed to have triggered financial incentives that are witnessed to have stood against better patient care, while enabling for-profit companies to conquer the business.
It is claimed that today a majority of the hospitals extended most of the care on a nonprofit basis following the initiation of end-stage-renal-disease program. However, it got spurred by the guarantee of Medicare money.
The current figures outline that more than 80 % of the nation's 5,000 clinics work on profit basis. Besides, over 66% of all clinics are controlled by two chains: Colorado-based DaVita and Fresenius.